|
[1]
|
Arnoux JB,Verkarre V,Samt-Martm C,et al.Congenital hyperin-sulinism:current trends in diagnosis and therapy[J].Orphanet J Rare Dis,2011,6:63. |
|
[2]
|
Arnoux JB,de Lonlay P,Ribeiro MJ,et al.Congenital hyperin-sulinism[J].Early Hum Dev,2010,86(5):287-294. |
|
[3]
|
Bellanné-Chantelot C,Saint-Martin C,Ribeiro M J,et al.ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism[J].J Med Genet,2010,47(11):752-759. |
|
[4]
|
Ismail D,Hussain K.Role of 18F-DOPA PET/CT imaging in con-genital hyperinsulinism[J].Rev Endocr Metab Disord,2010,11(3):165-169. |
|
[5]
|
Hussain K,Seppänen M,Nänto-Salönen K,et al.The diagnosis ofectopic focal hyperinsulinism of infancy with[18F]-dopa positronemission tomography[J].J Clin Endocrinol Metab,2006,91(8):2839-2842. |
|
[6]
|
Peranteau W H,Bathaii SM,Pawel B,et al.Multiple ectopic lesions of focal islet adenomatosis identified by positron emission tomogra-hy scan in an infant with congenital hyperinsulinism[J].J Pediatr Surg,2007,42(1): 188-192. |
|
[7]
|
Otonkoski T,Näntö-Salonen K,Seppänen M,et al.Noninvasive di-gnosis of focal hyperinsulinism of infancy with[18F]-DOPA positron emission tomography[J].Diabetes,2006,55(1): 13-18. |
|
[8]
|
de Lonlay P,Simon-Carre A,Ribeiro M J,et al.Congenital hyper-nsulinism: pancreatic[18F]fluoro-L-dihydroxyphenylalanine(DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion[J].J Clin Endocrinol Metab,2006,91(3): 933-940. |
|
[9]
|
Meintjes M,Endozo R,Dickson J,et al.18F-DOPA PET and en-anced CT imaging for congenital hyperinsulinism: initial UK ex-erience from a technologist's perspective[J].Nucl Med Commun,2013,34(6):601-608. |
|
[10]
|
Koopmans KP,Neels ON,Kema IP,et al.Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results[J].Crit Rev Oncol Hematol,2009,71(3): 199-213. |
|
[11]
|
Jager PL,Chirakal R,Marriott CJ,et al.6-L-18F-fluorodihydrox-yphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications[J].J Nucl Med,2008,49(4): 573-586. |
|
[12]
|
Ribeiro MJ,De Lonlay P,Delzescaux T,et al.Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA[J].J Nucl Med,2005,46(4): 560-566. |
|
[13]
|
Mohnike K,Blankenstein O,Minn H,et al.[18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism[J].Horm Res,2008,70(2): 65-72. |
|
[14]
|
Laje P,States LJ,Zhuang H,et al.Accuracy of PET/CT Scan in the diagnosis of the focal form of congenital hyperinsulinism[J].J Pedi-atr Surg,2013,48(2): 388-393. |
|
[15]
|
Capito C,Khen-Dunlop N,Ribeiro MJ,et al.Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in con-enital hyperinsulinism[J].Radiology,2009,253(1): 216-222. |
|
[16]
|
Zani A,Nah SA,Ron O,et al.The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission to-ography-computed tomography scans in children with congenital hyperinsulinism of infancy[J].J Pediatr Surg,2011,46(1): 204-208. |
|
[17]
|
Masue M,Nishibori H,Fukuyama S,et al.Diagnostic accuracy of [18F]-fluoro-L-dihydroxyphenylalanine positron emission tomogra-hy scan for persistent congenital hyperinsulinism in Japan[J].Clin Endocrinol(Oxf),2011,75(3): 342-346. |
|
[18]
|
Yang J,Hao R,Zhu X.Diagnostic role of 18F-dihydroxyphenylala-nine positron emission tomography in patients with congenital hy-perinsulinism: a meta-analysis[J].Nucl Med Commun,2013,34(4): 347-353. |
|
[19]
|
Yang J,Yuan L,Meeks J K,et al.18F-DOPA positron emission to mography/computed tomography application in congenital hyperin-sulinism[J].J Pediatr Endocrinol Metab,2012,25(7-8): 619-622. |
点击查看大图
下载: